Literature DB >> 25644575

Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N.

Roopa Jones Ganji1, Ravikumar Reddi, Rajesh Gumpena, Anil Kumar Marapaka, Tarun Arya, Priyanka Sankoju, Supriya Bhukya, Anthony Addlagatta.   

Abstract

Actinonin is a pseudotripeptide that displays a high affinity towards metalloproteases including peptide deformylases (PDFs) and M1 family aminopeptidases. PDF and M1 family aminopeptidases belong to thermolysin-metzincin superfamily. One of the major differences in terms of substrate binding pockets between these families is presence (in M1 aminopeptidases) or absence (in PDFs) of an S1 substrate pocket. The binding mode of actinonin to PDFs has been established previously; however, it is not clear how the actinonin, without a P1 residue, would bind to the M1 aminopeptidases. Here we describe the crystal structure of Escherichia coli aminopeptidase N (ePepN), a model protein of the M1 family aminopeptidases in complex with actinonin. For comparison we have also determined the structure of ePepN in complex with a well-known tetrapeptide inhibitor, amastatin. From the comparison of the actinonin and amastatin ePepN complexes, it is clear that the P1 residue is not critical as long as strong metal chelating head groups, like hydroxamic acid or α-hydroxy ketone, are present. Results from this study will be useful for the design of selective and efficient hydroxamate inhibitors against M1 family aminopeptidases.
© 2015 The Protein Society.

Entities:  

Keywords:  M1 aminopeptidase; actinonin; amastatin; matrix metalloproteinase; peptide deformylase

Mesh:

Substances:

Year:  2015        PMID: 25644575      PMCID: PMC4420530          DOI: 10.1002/pro.2653

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  43 in total

1.  Announcing the worldwide Protein Data Bank.

Authors:  Helen Berman; Kim Henrick; Haruki Nakamura
Journal:  Nat Struct Biol       Date:  2003-12

2.  Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.

Authors:  Adrien Boularot; Carmela Giglione; Sylvain Petit; Yann Duroc; Rodolphe Alves de Sousa; Valéry Larue; Thierry Cresteil; Frédéric Dardel; Isabelle Artaud; Thierry Meinnel
Journal:  J Med Chem       Date:  2007-01-11       Impact factor: 7.446

Review 3.  Antibiotics in the clinical pipeline in 2013.

Authors:  Mark S Butler; Mark A Blaskovich; Matthew A Cooper
Journal:  J Antibiot (Tokyo)       Date:  2013-09-04       Impact factor: 2.649

4.  Antitumor activity of actinonin in vitro and in vivo.

Authors:  Y Xu; L T Lai; J L Gabrilove; D A Scheinberg
Journal:  Clin Cancer Res       Date:  1998-01       Impact factor: 12.531

5.  Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro.

Authors:  Soma Sengupta; Peleg M Horowitz; Stanislav L Karsten; George R Jackson; Daniel H Geschwind; Yifan Fu; Robert W Berry; Lester I Binder
Journal:  Biochemistry       Date:  2006-12-19       Impact factor: 3.162

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322.

Authors:  Karen O'Dwyer; Meredith Hackel; Sarah Hightower; Daryl Hoban; Samuel Bouchillon; Donghui Qin; Kelly Aubart; Magdalena Zalacain; Deborah Butler
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

8.  Differential regulation of aminopeptidase N (CD13) by transendothelial migration and cytokines on human eosinophils.

Authors:  Ruedi K Braun; Martin Foerster; Grefachew Workalemahu; Daniela Haefner; Claus Kroegel; Christoph Walker
Journal:  Exp Lung Res       Date:  2003-03       Impact factor: 2.459

9.  A new human peptide deformylase inhibitable by actinonin.

Authors:  Mona D Lee; Christophe Antczak; Yueming Li; Francis M Sirotnak; William G Bornmann; David A Scheinberg
Journal:  Biochem Biophys Res Commun       Date:  2003-12-12       Impact factor: 3.575

10.  A naturally variable residue in the S1 subsite of M1 family aminopeptidases modulates catalytic properties and promotes functional specialization.

Authors:  Seema Dalal; Daniel R T Ragheb; Florian D Schubot; Michael Klemba
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

View more
  3 in total

1.  Small molecule inhibition of apicomplexan FtsH1 disrupts plastid biogenesis in human pathogens.

Authors:  Katherine Amberg-Johnson; Sanjay B Hari; Suresh M Ganesan; Hernan A Lorenzi; Robert T Sauer; Jacquin C Niles; Ellen Yeh
Journal:  Elife       Date:  2017-08-18       Impact factor: 8.140

2.  Aminobenzosuberone Scaffold as a Modular Chemical Tool for the Inhibition of Therapeutically Relevant M1 Aminopeptidases.

Authors:  Emmanuel Salomon; Marjorie Schmitt; Anil Kumar Marapaka; Athanasios Stamogiannos; Germain Revelant; Céline Schmitt; Sarah Alavi; Isabelle Florent; Anthony Addlagatta; Efstratios Stratikos; Céline Tarnus; Sébastien Albrecht
Journal:  Molecules       Date:  2018-10-11       Impact factor: 4.411

3.  Inhibitors of BMP-1/tolloid-like proteinases: efficacy, selectivity and cellular toxicity.

Authors:  Maya Talantikite; Pascaline Lécorché; Fabrice Beau; Odile Damour; Christoph Becker-Pauly; Wen-Bin Ho; Vincent Dive; Sandrine Vadon-Le Goff; Catherine Moali
Journal:  FEBS Open Bio       Date:  2018-11-12       Impact factor: 2.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.